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a b s t r a c t
Psychogenic non-epileptic seizures (PNES) are the main differential diagnosis of pharmacorresistant epilepsy. Achieving
the certainty in the diagnosis of PNES may be challenging,
especially in the 10-22% of cases in which PNES and epilepsy
co-exist. This diﬃculty hampers the management of these
patients. Unfortunately, published series with this combined
pathology are scarce and small in size.
This article presents the dataset of our article “Factors associated with comorbid epilepsy in patients with psychogenic
non-epileptic seizures: a large cohort study” (Massot-Tarrús
et al. 2022). It is composed by a detailed demographic and
clinical data of 271 consecutive patients diagnosed with PNES
in our epilepsy monitoring unit (EMU) between May 2001
and February 2011, and followed until September 2016. Based
on the clinical, neuroimaging and vEEG ﬁndings, 47 of these
patients were diagnosed with deﬁnite comorbid epilepsy, and
30 with possible or probable comorbid epilepsy. All data was
collected retrospectively from chart review.

DOI of original article: 10.1016/j.yebeh.2022.108780
Corresponding author:
E-mail address: amassot@mutuaterrassa.cat (A. Massot-Tarrús).
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The cohort is depicted by means of demographic variables;
age at PNES onset; years with PNES; frequency of PNES; duration of longest PNES seizure; self-reported history of minor head trauma (not associated with an increased risk of
epilepsy) immediately preceding the ﬁrst PNES; history of
substance abuse; past or present history of active suicidal
ideation; neuropsychological evaluation with the Minnesota
Multiphasic Personality Inventory test; number and nature of
risk factors for epilepsy; co-morbid degenerative brain disease or other neurological or psychiatric medical conditions;
semiology of the seizures and triggers; EEG ﬁndings; type of
epilepsy; number of past EMU admissions and epilepsy clinic
visits and re-referrals; number of Anti-Seizure Medications
(ASM) at EMU admission and discharge; and the outcome of
the spells and ASM after the EMU discharge. Those ASM prescribed for reasons other than the treatment of the seizures
(e.g., psychiatric disorders, migraine, pain syndromes, etc.)
were not counted.
The presented baseline data can be used in studies evaluating the characteristics of patients with PNES and comorbid
epilepsy, and in the creation of algorithms to identify them.
It could facilitate the prioritization of this subgroup of patients for prolonged video-EEG monitorization to conﬁrm the
co-existence of both types of seizures and treat them accordingly.
© 2022 The Authors. Published by Elsevier Inc.
This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/)

Speciﬁcations Table
Subject
Speciﬁc subject area
Type of data
How the data were acquired

Data format
Description of data collection

Data source location

Data accessibility
Related research article

Clinical Neurology
Risk factors associated with the coexistence of epilepsy in patients with
psychogenic non-epileptic seizures.
Table
All was acquired retrospectively from a comprehensive chart review at the London
Health Sciences Centre (LHSC, London, Canada) performed by two neurologists
with expertise in the ﬁeld of epilepsy (Y.J.Y. and M.A.), covering the period
preceding the diagnosis of PNES until either the last follow-up visit or September
2016, whichever came ﬁrst, to ensure that the ﬁnal diagnosis was not revised.
A predetermined table with the demographic and clinical variables of interest was
created in an excel ﬁle to complete.
Raw
We enrolled consecutive patients admitted to the EMU at LHSC. Patients were
included if EMU admission documented a new diagnosis of PNES based on two
habitual seizures or single prolonged psychogenic seizure (lasting more than 30
mins.) captured after a prolonged video EEG monitoring. Two seizures were
required for added certainty because PNES have a higher rate of variability in
appearance compared to the ES.
Institution: London Health Sciences Centre (LHSC, London, Canada).
City/Region: London, Ontario.
Country: Canada.
Data identiﬁcation number: DOI: 10.17632/gmwkgkkyk6.3
Direct URL to data: https://data.mendeley.com/datasets/gmwkgkkyk6/3
A. Massot-Tarrús, Y. Joe Yu, M. AlKhateeb, S.M. Mirsattari. Factors associated with comorbid epilepsy in patients with psychogenic nonepileptic seizures:
A large cohort study, Epilepsy Behav. 23 (2022) 108780.
https://doi.org/10.1016/j.yebeh.2022.108780.

A. Massot-Tarrús, Y.J. Yu and M. AlKhateeb et al. / Data in Brief 45 (2022) 108568

3

Value of the Data
• This dataset provides the demographic and clinical characterization of a large cohort of patients with PNES alone or with comorbid epilepsy. The latest is a subgroup of patients with
scarce information available in the literature.
• This dataset could be valuable to researchers considering future comparative studies of patients with PNES vs epilepsy alone, or patients with PNES vs PNES and comorbid epilepsy.
• This data can be used for the development of algorithms to identify patients with PNES
at higher risk of suffering comorbid epilepsy. Such algorithms might improve the costeffectiveness of prolonged video-EEG monitorization, shortening the time to diagnosis, and
avoiding unnecessary treatments.

1. Data Description
Table 1 shows the raw dataset of patients diagnosed with Psychogenic non-epileptic seizures
(PNES) in our Epilepsy Monitoring Unit (EMU) between May 2001 and February 2011, and their
follow-up until the last follow-up visit or September 2016. It includes patients with or without
comorbid epilepsy [1].
The following demographic and clinical variables are included in the table: gender, age at the
EMU admission, number of children, marital status, maximum education degree, present and
past employment status, valid or suspended driving license and reason, age at PNES onset and
years with PNES, frequency of PNES at the time of EMU admission, duration of longest PNES
seizure according to either patient or witness (whichever was considered more accurate), report of minor head trauma - stated as a concussion or lesser injury that should not cause an
increased risk of epilepsy- by the patient as immediately preceding the initial PNES, neuropsychological evaluation (with the Minnesota Multiphasic Personality Inventory test) results, family history of epilepsy, personal history of febrile seizures, developmental disabilities, meningitis/meningoencephalitis, traumatic brain injury – as amnesia, alteration or loss of consciousness
or neurologic deﬁcits after a blow to head [2, 3] - brain lesions on neuroimaging considered of
risk for epilepsy, history of substance abuse, dementia (Alzheimer’s disease or any other), other
neurological or psychiatric medical conditions, history of active suicidal ideation, description of
the seizures signs and symptoms, their auras and triggers, EEG ﬁndings, type of epilepsy if associated, number of Anti-Seizure Medications (ASM) at EMU admission and discharge, and the
outcome of the spells and ASM intake during the follow-up after the EMU discharge (only ASM
prescribed for the treatment of the seizures where counted).
The categories in which each variable was divided are described in the headline of the
columns.
The deﬁnitions, coding and calculation of the variables are described in a second sheet in the
same excel ﬁle.

2. Experimental Design, Materials and Methods
The design of the study is retrospective case-control.
Enrolment of patients was done at the time of their admission to the EMU of the London
Health Sciences Centre (LHSC, London, Ontario, Canada), between May 2001 and February 2011.
The inclusion criteria were the diagnosis of PNES based on the recording of two usual spells or
a single prolonged spell (lasting 30 minutes or more) captured during the video EEG monitorization. The diagnosis was made in all cases by a certiﬁed epileptologist and electroencephalographer for the Canadian Society of Clinical Neurophysiologists, meeting therefore the highest
level of diagnostic certainly (“Documented PNES”) according to the International League Against
Epilepsy (ILAE) [4]. Two seizures were required to reinforce the certainty of the diagnosis, since
PNES have a higher rate of inconsistency compared to epileptic seizures.
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A predetermined excel table with the deﬁned demographic and clinical variables of interest
was created. The table was ﬁlled by two neurologists with proﬁciency in the ﬁeld of epilepsy
(Y.J.Y. and M.A.). In order to do this, the two neurologists performed a comprehensive retrospective chart review of each patient (including clinic notes, discharge summaries, psychology reports and other documents dictated right after the patient encounters) covering the period preceding the diagnosis of PNES until either September 2016 or the last follow-up visit, whichever
came ﬁrst. 235/271 patients had follow-up visits (136 with a short-term follow-up and 120 with
a long-term follow-up timepoint).
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